Takeda addressing Gammagard Liquid supplies but says it will take time
admin 15th May 2019 Uncategorised 0Shire opened a new $1 billion plant in the U.S. in October, and the first product that will come out will be its immune deficiency treatment Gammagard Liquid. But given the long lead time needed to produce and deliver the rare disease drug to the market, a tight supply is projected to continue through this year.
More: Takeda addressing Gammagard Liquid supplies but says it will take time
Source: fierce